Researcher
Huzhou Normal University
5 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 8, 2026 · PREPRINT
arXiv
A system design paper describing an implemented fraud detection tool with reported deployment outcomes but without controlled experimental validation, comparative statistics, or peer review.
SEP 8, 2026 · JOURNAL ARTICLE
PLOS Computational Biology
This is a mechanistic study using computational and functional approaches to characterize a non-coding RNA's role in cancer, raising questions about therapeutic potential rather than testing clinical efficacy or providing definitive evidence of practice-changing utility.
SEP 7, 2026 · JOURNAL ARTICLE
Frontiers in Immunology
A narrative mechanism-based review synthesizing evidence across drug classes to guide clinical decision-making in cervical cancer treatment, without presenting original trial data or meta-analytic synthesis.
AUG 19, 2026 · PREPRINT
arXiv
A machine-learning proof-of-concept on a single regional dataset (180 Chinese beach profiles) with no clinical or translational validation, comparative effectiveness trial, or independent external validation reported.
JUL 30, 2026 · JOURNAL ARTICLE
Frontiers in Immunology
This is a narrative review that synthesizes mechanistic evidence and emerging therapeutic concepts without reporting primary trial data, clinical outcomes, or comparative effectiveness.